explain how bifunctional enzyme PFK2/FBPase2 controls the level of the PFK1 allosteric regulator fructose 2,6 bisphosphate. integrate with insulin/glucagon signaling
PFK2 uses some fructose-6-phosphate to create F-2,6-BP which is a potent activator of the enzyme PFK1 which facilitates glycolysis
FBPase2 is an inhibitory enzyme that reduces concentration of F-2,6-BP and increases activation of F-1,6-BPase which converts fructose-1,6-bisphosphate to fructose-6-ohosphate and facilitates gluconeogenesis
in states of high blood sugar levels, Insulin will be released and PFK2 will be activated to catalyze glycolysis PFK2 will use some fructose-6-phosphate to create fructose-2,6-bisphosphate which will highly catalyze the activity of PFK1 to turn fructose-6-phosphate to fructose-1,6-bisphosphate for glycolysis
in states of low blood sugar levels, glucagon will be released and FBPase2 will predominate and decrease the concentration of F 2,6 bpase and F1,6BPase will activate to catalyze gluconeogenesis
when the PKF2 domain of the bifunctional enzyme is phosphorylated, gluconeogenesis is activated due to the increased activity of fructose-1,6-bisphosphatase
when the PFK2 domain is not phosphorylated, glycolysis prevails as PFK2 is active